Jess Lambrechtsen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Coronary Artery Disease

Randomized Controlled Trial

Top Venues

Cardiovascular diabetology

Diabetes & vascular disease research

This page only lists publications with an associated author ORCID identifier.

Publications

Axel Cosmus Pyndt Diederichsen, Anna Mejldal, Rikke Søgaard, Nina Sahlertz Kristiansen, Jess Lambrechtsen, Flemming Hald Steffensen, Lars Frost, Kenneth Egstrup, Martin Busk, Grazina Urbonaviciene, Marek Karon, Christina Lund Kidholm, Jes Sanddal Lindholt
User-defined outcomes of the Danish cardiovascular screening (DANCAVAS) trial: A post hoc analyses of a population-based, randomised controlled trial. PLoS medicine 21 (5) (2024)
Axel Cosmus Pyndt Diederichsen, Anna Mejldal, Rikke Søgaard, Nina Sahlertz Kristiansen, Jess Lambrechtsen, Flemming Hald Steffensen, Lars Frost, Kenneth Egstrup, Martin Busk, Grazina Urbonaviciene, Marek Karon, Christina Lund Kidholm, Jes Sanddal Lindholt
User-defined outcomes of the Danish cardiovascular screening (DANCAVAS) trial: A post hoc analyses of a population-based, randomised controlled trial. PLoS medicine 21 (5) (2024)
Katrine Schultz Overgaard, Roda Abdulkadir Mohamed, Thomas Rueskov Andersen, Jess Lambrechtsen, Kenneth Egstrup, Søren Auscher
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial. Cardiovascular diabetology 23 (1) (2024)
Katrine Schultz Overgaard, Roda Abdulkadir Mohamed, Thomas Rueskov Andersen, Jess Lambrechtsen, Kenneth Egstrup, Søren Auscher
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial. Cardiovascular diabetology 23 (1) (2024)
Axel Cosmus Pyndt Diederichsen, Anna Mejldal, Rikke Søgaard, Nina Sahlertz Kristiansen, Jess Lambrechtsen, Flemming Hald Steffensen, Lars Frost, Kenneth Egstrup, Martin Busk, Grazina Urbonaviciene, Marek Karon, Christina Lund Kidholm, Jes Sanddal Lindholt
User-defined outcomes of the Danish cardiovascular screening (DANCAVAS) trial: A post hoc analyses of a population-based, randomised controlled trial. PLoS medicine 21 (5) (2024)
Katrine Schultz Overgaard, Roda Abdulkadir Mohamed, Thomas Rueskov Andersen, Jess Lambrechtsen, Kenneth Egstrup, Søren Auscher
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial. Cardiovascular diabetology 23 (1) (2024)
Axel Cosmus Pyndt Diederichsen, Anna Mejldal, Rikke Søgaard, Nina Sahlertz Kristiansen, Jess Lambrechtsen, Flemming Hald Steffensen, Lars Frost, Kenneth Egstrup, Martin Busk, Grazina Urbonaviciene, Marek Karon, Christina Lund Kidholm, Jes Sanddal Lindholt
User-defined outcomes of the Danish cardiovascular screening (DANCAVAS) trial: A post hoc analyses of a population-based, randomised controlled trial. PLoS medicine 21 (5) (2024)
Katrine Schultz Overgaard, Roda Abdulkadir Mohamed, Thomas Rueskov Andersen, Jess Lambrechtsen, Kenneth Egstrup, Søren Auscher
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial. Cardiovascular diabetology 23 (1) (2024)
Axel Cosmus Pyndt Diederichsen, Anna Mejldal, Rikke Søgaard, Nina Sahlertz Kristiansen, Jess Lambrechtsen, Flemming Hald Steffensen, Lars Frost, Kenneth Egstrup, Martin Busk, Grazina Urbonaviciene, Marek Karon, Christina Lund Kidholm, Jes Sanddal Lindholt
User-defined outcomes of the Danish cardiovascular screening (DANCAVAS) trial: A post hoc analyses of a population-based, randomised controlled trial. PLoS medicine 21 (5) (2024)
Katrine Schultz Overgaard, Thomas Rueskov Andersen, Roda Abdulkadir Mohamed, Laurits J Heinsen, Helle G Binderup, Sören Möller, Søren Auscher, Jess Lambrechtsen, Kenneth Egstrup
Can prediabetes diagnosed using HemoglobinA1c or oral glucose tolerance test predict presence and severity of coronary artery disease in symptomatic patients? Diabetes & vascular disease research 20 (3) (2023)